Hill Raymond H 4
4 · PHARMACEUTICAL PRODUCT DEVELOPMENT INC · Filed Dec 6, 2011
Insider Transaction Report
Form 4
Hill Raymond H
DirectorChief Executive Officer
Transactions
- Disposition to Issuer
Stock Options (to buy)
2011-12-05−150,000→ 0 totalExercise: $28.54Exp: 2021-09-16→ Common Stock (150,000 underlying) - Disposition to Issuer
Restricted Stock
2011-12-05−30,000→ 0 total
Footnotes (2)
- [F1]The shares of restricted stock were disposed of pursuant to the Agreement and Plan of Merger (the "Agreement"), by and among Pharmaceutical Product Development, Inc., Jaguar Holdings LLC and Jaguar Merger Sub, Inc. dated as of October 2, 2011, on the effective date of the merger contemplated by the Agreement (the "Merger"), and exchanged for 99,750 shares of Jaguar Holding Company I, Inc. common stock having a market value of $10.00 per share on the effective date of the Merger.
- [F2]This option, which was scheduled to vest in three equal installments on September 16, 2012, September 16, 2013 and September 16, 2014, was cancelled pursuant to the Agreement and replaced with an option to purchase 498,750 shares of Jaguar Holding Company I, Inc.common stock having a market value of $10.00 per share on the effective date of the Merger.